Publications by authors named "Leonid S Metelitsa"

32Publications

A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor.

Cancer Immunol Res 2020 01 12;8(1):57-69. Epub 2019 Nov 12.

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article and Find Full Text PDF
January 2020

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.

Cancer Immunol Res 2019 03 16;7(3):363-375. Epub 2019 Jan 16.

Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, Texas.

View Article and Find Full Text PDF
March 2019

IL-21 Selectively Protects CD62L NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.

J Immunol 2018 10 15;201(7):2141-2153. Epub 2018 Aug 15.

Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030;

View Article and Find Full Text PDF
October 2018

G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Cancer Res 2015 Jun 23;75(12):2566-79. Epub 2015 Apr 23.

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Houston, Texas. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.

View Article and Find Full Text PDF
June 2015

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system.

Cancer Res 2014 Nov 11;74(21):6260-70. Epub 2014 Sep 11.

Department of Pediatrics, Texas Children's Cancer Center, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.

View Article and Find Full Text PDF
November 2014

Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.

Blood 2014 Oct 21;124(18):2824-33. Epub 2014 Jul 21.

Texas Children's Cancer Center, Department of Pediatrics, Department of Pathology and Immunology, Center for Cell and Gene Therapy, and.

View Article and Find Full Text PDF
October 2014

Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells.

Clin Immunol 2013 Oct 18;149(1):55-64. Epub 2013 Jun 18.

Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.

View Article and Find Full Text PDF
October 2013

G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.

Cancer Res 2013 Jul 16;73(13):4134-46. Epub 2013 May 16.

Division of Pediatric Surgery, Michael E DeBakey Department of Surgery, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
July 2013

C-Glycosphingolipids with an exo-methylene substituent: stereocontrolled synthesis and immunostimulation of mouse and human natural killer T lymphocytes.

Chembiochem 2012 Aug 10;13(12):1733-7. Epub 2012 Jul 10.

Department of Chemistry and Biochemistry, Queens College of The City University of New York, Flushing, NY 11367, USA.

View Article and Find Full Text PDF
August 2012

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.

J Clin Invest 2012 Jun 8;122(6):2221-33. Epub 2012 May 8.

Department of Pediatrics and Department of Pathology and Immunology, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
June 2012